Publication | Closed Access

Isoalantolactone inhibits LPS-induced inflammation via NF-κB inactivation in peritoneal macrophages and improves survival in sepsis

InflammationAnti-inflammatoryLung InflammationLps-induced InflammationMedicinePeritoneal MacrophagesImmunologyChronic InflammationSepsisInflammation BiologyNf-κb InactivationInnate ImmunityPharmacologyInflammatory DiseasePhagocyte